obesity

Question 1

Underweight

Answer 1

<18.5

Question 2

normal

Answer 2

18.5-24.9

Question 3

overweight

Answer 3

25-29-9

Question 4

obese

Answer 4

30-34.9 class I
35-39.9 class II

Question 5

extremely obesity

Answer 5

> =40 class III

Question 6

obesity disease process

Answer 6

• fat mass disease
• adiposopathy
• metabolically healthy obesity

Question 7

Fat mass disease: result of abnormal and pathologic physical forces

Answer 7

i. Stress on weight bearing joints
ii. Tissue compression: Sleep apnea, GERD
iii. Tissue friction: Intertrigo

Question 8

adiposopathy: result of improper endocrine and immune responses

Answer 8

i. Elevated blood glucose
ii. Elevated blood pressure
iii. Dyslipidemia
iv. Other metabolic concerns

Question 9

metabolically healthy obesity

Answer 9

i. Low liver fat
ii. Low inflammation
iii. No adiposopathy but at risk for fat mass disease

Question 10

Metabolic syndrome

Answer 10

Criteria for diagnosis (3 of 5)

i. Elevated waist circumference
1. 102 cm (40 inches) in men, 88 cm (35 inches) in women
ii. Elevated triglycerides >150 mg/dL
iii. Reduced HDL-C <40 mg/dL in men, <50 mg/dL in women
iv. Elevated blood pressure >130 mm Hg systolic blood pressure or 85 mm Hg diastolic blood pressure
v. Elevated fasting glucose 100 mg/dL

Question 11

Absolute risk status

Answer 11

STAGE 1-5

Question 12

STAGE 0

Answer 12

No apparent risk factors, physical symptoms, psychopathology, functional limitations and/or impairment of well-being related to obesity (e.g., blood pressure, serum lipid and fasting glucose levels within normal range)

Question 13

STAGE 1:

Answer 13

Presence of obesity-related subclinical risk factors, mild physical symptoms, mild psychopathology, mild functional limitations and/or mild impairment of well-being (e.g., borderline hypertension, impaired fasting glucose levels, elevated levels of liver enzymes), (e.g. dyspnea on moderate exertion, occasional aches and pains, fatigue)

Question 14

STAGE 2:

Answer 14

Presence of established obesity-related chronic disease, moderate limitations in activities of daily living and/or well-being (e.g., hypertension, type 2 diabetes, sleep apnea, osteoarthritis)

Question 15

STAGE 3:

Answer 15

Established end-organ damage, significant psychopathology, significant functional limitations and/or impairment of well-being such as myocardial infarction, heart failure, stroke

Question 16

STAGE 4:

Answer 16

Severe (potentially end-stage) disabilities from obesity-related chronic diseases, severe disabling psychopathology, severe functional limitations and/or severe impairment of well-being